3Stowasser M.Primary aldosteronism:revival of a syndrome.J Hypertens,2001,19:363-366. 被引量：1
4Nishizaka MK,Calhoun DA.The role of aldosterone antagonists in the management of resistant hypertension.Curr Hypertens Rep,2005,7:343-347. 被引量：1
5Gordon RD.Primary aldosteronism--actual epidemics or false alarm?Arq Bras Endocrinol Metabol,2004,48:666-673. 被引量：1
6Hiramatsu K,Yamada T,Yukimura Y,et al.A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity.Results in hypertensive patients.Arch Intern Med,1981,141:1589-1593. 被引量：1
7Young WF.Primary aldosteronism-changing concepts in diagnosis and treatment.Endocrinology,2003,144:2208-2213. 被引量：1
8Calhoun DA,Nishizawa MK,Zaman MA,et al.Hyperaldosteronism among black and white subjects with resistant hypertension.Hypertension,2002,40:892-896. 被引量：1
9Montori VM,Young WF.Use of plasma aldosterone concentration-toplasma renin activity ratio as a screening test for primary aldosteronism.A systematic review of the literature.Endocrinol Metab Clin North Am,2002,31:619-632 被引量：1
10Stowasser M,Gordon RD,Gunasekera TG,et al.High rate of detection of primary aldosteronism,including surgically treatable forms,after 'non-selective' screening of hypertensive patients.J Hypertens,2003,21:2149-2157. 被引量：1
